Breathe easy: new inhaler could shield heart during stent procedure
NCT ID NCT07397351
First seen Feb 09, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study tests an inhaled medicine called Aroxxen in 180 people with coronary artery disease who are getting a stent to open blocked heart arteries. The goal is to see if breathing in the drug during and after the procedure can reduce heart muscle damage and find the best dose and treatment length. Participants are randomly assigned to receive Aroxxen or standard care, and researchers will monitor safety and heart injury markers in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City Multidisciplinary Hospital No. 2
RECRUITINGSaint Petersburg, Russia
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.